| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9861 |
| Human Intestinal Absorption | HIA+ | 0.9739 |
| Caco-2 Permeability | Caco2+ | 0.8059 |
| P-glycoprotein Substrate | Substrate | 0.6559 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8838 |
| Inhibitor | 0.8826 |
| Renal Organic Cation Transporter | Inhibitor | 0.7098 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6208 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7898 |
| CYP450 2D6 Substrate | Substrate | 0.8919 |
| CYP450 3A4 Substrate | Substrate | 0.6698 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.8932 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9094 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6132 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6083 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9065 |
| Inhibitor | 0.8271 |
| AMES Toxicity | Non AMES toxic | 0.8109 |
| Carcinogens | Non-carcinogens | 0.9021 |
| Fish Toxicity | High FHMT | 0.9301 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8784 |
| Honey Bee Toxicity | Low HBT | 0.7622 |
| Biodegradation | Not ready biodegradable | 0.9886 |
| Acute Oral Toxicity | II | 0.5126 |
| Carcinogenicity (Three-class) | Non-required | 0.6223 |